NORCET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norcet, and what generic alternatives are available?
Norcet is a drug marketed by Abana and is included in one NDA.
The generic ingredient in NORCET is acetaminophen; hydrocodone bitartrate. There is one drug master file entry for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORCET?
- What are the global sales for NORCET?
- What is Average Wholesale Price for NORCET?
Summary for NORCET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | NORCET at DailyMed |
US Patents and Regulatory Information for NORCET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abana | NORCET | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 088871-001 | May 15, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
